治疗慢性失眠的达里多雷克桑:一个现实世界的回顾性单中心研究
Mariana Fernandes1, Fabio Placidi1,2, Nicola Biagio Mercuri1,2
1Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
概括
达里多雷克桑特有效治疗慢性失眠障碍 (CID) 在现实世界的成年患者中,显示显著的症状改善和良好的安全性. 这种双素受体阻断剂为CID管理提供了一个有前途的选择.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 慢性失眠障碍 (CID) 严重影响日常生活和福祉.
- 达里多雷克桑 (Daridorexant) 是一种新型的双素受体对抗剂,已被批准用于成人CID治疗.
- 关于daridorexant的有效性和安全性的真实世界数据至关重要.
研究的目的:
- 评估达里多雷克桑特在患有慢性发作症的成年患者中的实际有效性和安全性.
- 描述影响治疗结果的患者和临床特征.
- 评估达里多雷克桑特对失眠严重程度和患者报告的改善的影响.
主要方法:
- 对连续开始服用达里多雷克桑的患者进行了回顾性观察性研究.
- 数据收集包括患者的人口统计,并发症和治疗史.
- 在30天随访时的评估使用了临床和患者的全球印象改善 (CGI-I/PGI-I) 和失眠严重程度指数 (ISI) 评分.
主要成果:
- 58%的患者和临床医生报告了CID症状的改善 (CGI-I/PGI-I).
- 失眠严重程度指数 (ISI) 的得分显著下降 (18.25至12.08,p < 0.001).
- 没有报告严重的不良事件;33.3%的患者没有失眠症状.
结论:
- 达里多雷克桑特 (Daridorexant) 证明了CID治疗的现实有效性和安全性.
- 它作为一线,开关或附加疗法是有效的.
- 需要在更大,更多样化的队伍中进行进一步的研究,以探索其全部潜力.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
176
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
176
Management of Insomnia
250
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
250
Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
Insomnia
86
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
86
Substance Use Disorders Affecting Sleep
167
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
167
Narcolepsy
103
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
103


